Posted by Michael Wonder on 12 Oct 2020
TGA grants provisional determination for COVID-19 vaccine
9 October 2020 - The Therapeutic Goods Administration has granted a provisional determination to AstraZeneca in relation to its COVID-19 Vaccine, ChAd0x1-S [recombinant].
The granting of a provisional determination means that the TGA has made a decision that AstraZeneca is now eligible to apply for provisional registration for the vaccine in the Australian Register of Therapeutic Goods (ARTG).
Provisional determination is the first step in the process and does not mean that an application has or will be made, or that the vaccine will be provisionally approved for inclusion in the ARTG.
